Effects and Costs of Hepatitis C Virus Elimination for the Whole Population in China: A Modelling Study-Reference-Cited by-同舟云学术

Effects and Costs of Hepatitis C Virus Elimination for the Whole Population in China: A Modelling Study

Published:2024-09-02 Issue: Volume: Page:
ISSN:1170-7690
Container-title:PharmacoEconomics
language:en
Short-container-title:PharmacoEconomics

Author:

Wu Meiyu,Ma Jing,Li Sini,Qin Shuxia,Tan Chongqing,Xie Ouyang,Li Andong,Lim Aaron G.,Wan Xiaomin^ORCID

Funder

National Natural Science Foundation of China

research project of the Health Commission of Hunan province

Fundamental Research Funds for Central Universities of the Central South University

Natural Science Foundation of Hunan Province

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40273-024-01424-5.pdf

Reference51 articles.

1. WHO. Global hepatitis report 2017.: World Health Organization; 2017.

2. Poordad F, Hezode C, Trinh R, Kowdley KV, Zeuzem S, Agarwal K, et al. ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis. N Engl J Med. 2014;370(21):1973–82 (2014-05-22).

3. WHO. Combating hepatitis B and C to reach elimination by 2030. Advocacy brief. Geneva: World Health Organization; 2016. https://www.who.int/publications/i/item/combating-hepatitis-b-and-c-to-reach-elimination-by-2030. Accessed 13 Jun 2022.

4. Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. Guideline for the prevention and treatment of hepatitis C (2022 version). Zhonghua Gan Zang Bing Za Zhi. 2022;30(12):1332–48.

5. Hui Z, Lai W, Guiqiang W. Healthy China 2030 white paper on action against the threat of Hepatitis C. http://www.cphcf.org.cn/zgcb/contents/650/30644.html. Accessed 13 Nov 2022.